An Open-Label Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn’s Disease (Holiday)

Brief Description Of Study

You are being asked to take part in this research study because you have Crohn’s disease and the medical treatments you have tried have not brought you to full remission (clinically and physically symptom free).

Clinical Study Identifier: TX1085

Detailed Study Description

If you agree to take part, your participation will last for 6-7 months and will involve 5 study visits each of approximately 60 minutes in length and 3 telephone calls each of approximately 30 minutes in length. You might be eligible to participate in this trial if: 1. You have Crohn’s Disease 2. You are between the ages of 18-64 3. You have tried multiple therapies with NO relief 4. You failed 8 weeks of: • Azathioprine • 6-mercaptopureine • Methotrexate • Adalimumab • Certolizumab • Golimumab • Infliximab • Natalizumab OR • Vedolizumab

Contact research investigator to learn more about this study by filling out the form below.


To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: An Open-Label Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn’s Disease (Holiday)
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.